Lumos Diagnostics Holdings Limited
LDXHF
$0.16
$0.00-0.93%
OTC PK
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 12.21M | 12.31M | 12.40M | 13.54M | 14.67M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 12.21M | 12.31M | 12.40M | 13.54M | 14.67M |
| Cost of Revenue | 4.62M | 4.67M | 4.72M | 5.06M | 5.39M |
| Gross Profit | 7.59M | 7.64M | 7.68M | 8.48M | 9.28M |
| SG&A Expenses | 15.98M | 14.55M | 13.12M | 12.56M | 11.99M |
| Depreciation & Amortization | 2.46M | 2.49M | 2.53M | 2.61M | 2.70M |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 23.33M | 21.90M | 20.47M | 20.32M | 20.17M |
| Operating Income | -11.11M | -9.59M | -8.07M | -6.78M | -5.50M |
| Income Before Tax | -9.26M | -8.22M | -7.18M | -6.08M | -4.98M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -9.26 | -8.22 | -7.18 | -6.08 | -4.98 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -9.26M | -8.22M | -7.18M | -6.08M | -4.98M |
| EBIT | -11.11M | -9.59M | -8.07M | -6.78M | -5.50M |
| EBITDA | -9.36M | -7.81M | -6.25M | -4.94M | -3.65M |
| EPS Basic | -0.01 | -0.01 | -0.01 | -0.01 | -0.01 |
| Normalized Basic EPS | -0.01 | -0.01 | -0.01 | -0.01 | -0.01 |
| EPS Diluted | -0.01 | -0.01 | -0.01 | -0.01 | -0.01 |
| Normalized Diluted EPS | -0.01 | -0.01 | -0.01 | -0.01 | -0.01 |
| Average Basic Shares Outstanding | 3.04B | 2.88B | 2.72B | 2.46B | 2.19B |
| Average Diluted Shares Outstanding | 3.04B | 2.88B | 2.72B | 2.46B | 2.19B |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |